The Lancet: 开放获取的COVID-19疫情流行病学数据

2020-03-24 公共卫生学术热点追踪 公共卫生学术热点追踪

牛津大学的研究人员于2020年2月19日在The Lancet InfectiousDiseases发表题为“Openaccess epidemiological data from th

牛津大学的研究人员于2020年2月19日在The Lancet InfectiousDiseases发表题为“Openaccess epidemiological data from the COVID-19 outbreak”的通讯文章。

2019年冠状病毒病(COVID-19)在中国迅速蔓延。在流行病早期,获得准确和可靠的流行病学、临床和实验室数据,对于指导公共卫生决策非常重要。流行病学信息的记录,了解传染性、地理传播风险、传播途径和感染风险因素,可为流行病学建模提供基线,为应对规划和控制措施提供信息。疫情暴发期间,很少能公开实时数据,使用各种模型和假设进行多种分析,有助于达成共识。这与基因组数据的开放共享存在相似之处。

研究人员建立了个人信息库,用于收集实验室确诊的COVID-19患者(在中国,通过在市和省疾病预防控制中心检测病毒核酸确认)病理信息,包括出行历史、位置(可用的最高分辨率和相应的经纬度)、症状和报告的发病日期,以及确认日期和基本人口统计数据。信息有多种来源,包括世卫组织、卫生部以及中国地方、省和国家卫生部门的官方报告。数据公开并定期更新(大约每天两次)。这些数据可为规划、建模和流行病学研究建立证据,更好地向公众、决策者、国际组织和资助者通报所处位置以及如何改进监测、应对工作和资源提供,这是控制COVID-19流行病的关键因素。

COVID-19流行病正在迅速蔓延,有必要建立计算基础设施,以应付的病例报告大量增加。数据共享对于评估和维持准确的病例报告至关重要。

原始出处:
Bo Xu, et al. Open access epidemiological data from the COVID-19 outbreak. The Lancet. Published:February 19, 2020

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1830543, encodeId=22b8183054366, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun Dec 06 02:20:39 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665756, encodeId=6c891665e56cb, content=<a href='/topic/show?id=aa8e49656e2' target=_blank style='color:#2F92EE;'>#开放获取#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49656, encryptionId=aa8e49656e2, topicName=开放获取)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770a25999447, createdName=ms4657536712156177, createdTime=Sat Dec 05 05:20:39 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381170, encodeId=47cd3811e0e7, content=學習了很有用不錯, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Tue Mar 31 01:14:29 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411348, encodeId=f9fa141134863, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Thu Mar 26 12:20:39 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=380928, encodeId=63bc380928a3, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Mar 24 22:48:36 CST 2020, time=2020-03-24, status=1, ipAttribution=)]
    2020-12-06 howi
  2. [GetPortalCommentsPageByObjectIdResponse(id=1830543, encodeId=22b8183054366, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun Dec 06 02:20:39 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665756, encodeId=6c891665e56cb, content=<a href='/topic/show?id=aa8e49656e2' target=_blank style='color:#2F92EE;'>#开放获取#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49656, encryptionId=aa8e49656e2, topicName=开放获取)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770a25999447, createdName=ms4657536712156177, createdTime=Sat Dec 05 05:20:39 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381170, encodeId=47cd3811e0e7, content=學習了很有用不錯, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Tue Mar 31 01:14:29 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411348, encodeId=f9fa141134863, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Thu Mar 26 12:20:39 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=380928, encodeId=63bc380928a3, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Mar 24 22:48:36 CST 2020, time=2020-03-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1830543, encodeId=22b8183054366, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun Dec 06 02:20:39 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665756, encodeId=6c891665e56cb, content=<a href='/topic/show?id=aa8e49656e2' target=_blank style='color:#2F92EE;'>#开放获取#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49656, encryptionId=aa8e49656e2, topicName=开放获取)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770a25999447, createdName=ms4657536712156177, createdTime=Sat Dec 05 05:20:39 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381170, encodeId=47cd3811e0e7, content=學習了很有用不錯, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Tue Mar 31 01:14:29 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411348, encodeId=f9fa141134863, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Thu Mar 26 12:20:39 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=380928, encodeId=63bc380928a3, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Mar 24 22:48:36 CST 2020, time=2020-03-24, status=1, ipAttribution=)]
    2020-03-31 飛歌

    學習了很有用不錯

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1830543, encodeId=22b8183054366, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun Dec 06 02:20:39 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665756, encodeId=6c891665e56cb, content=<a href='/topic/show?id=aa8e49656e2' target=_blank style='color:#2F92EE;'>#开放获取#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49656, encryptionId=aa8e49656e2, topicName=开放获取)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770a25999447, createdName=ms4657536712156177, createdTime=Sat Dec 05 05:20:39 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381170, encodeId=47cd3811e0e7, content=學習了很有用不錯, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Tue Mar 31 01:14:29 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411348, encodeId=f9fa141134863, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Thu Mar 26 12:20:39 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=380928, encodeId=63bc380928a3, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Mar 24 22:48:36 CST 2020, time=2020-03-24, status=1, ipAttribution=)]
    2020-03-26 xugumin
  5. [GetPortalCommentsPageByObjectIdResponse(id=1830543, encodeId=22b8183054366, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun Dec 06 02:20:39 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665756, encodeId=6c891665e56cb, content=<a href='/topic/show?id=aa8e49656e2' target=_blank style='color:#2F92EE;'>#开放获取#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49656, encryptionId=aa8e49656e2, topicName=开放获取)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770a25999447, createdName=ms4657536712156177, createdTime=Sat Dec 05 05:20:39 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381170, encodeId=47cd3811e0e7, content=學習了很有用不錯, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Tue Mar 31 01:14:29 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411348, encodeId=f9fa141134863, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Thu Mar 26 12:20:39 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=380928, encodeId=63bc380928a3, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Mar 24 22:48:36 CST 2020, time=2020-03-24, status=1, ipAttribution=)]
    2020-03-24 天地飞扬

    学习

    0

相关资讯

Pharmacological Research: 连花清瘟体外试验显示抗新冠病毒抗炎作用

中国工程院院士钟南山团队最新研究认为,连花清瘟在体外试验中显示出抗新冠病毒的作用。

Signal Transduction and Targeted Therapy: **皮质类固醇激素疗法对2019-nCoV严重肺炎的潜在益处

北京放射医学研究所等于2020年2月21日在Signal Transduction andTargeted Therapy期刊发表题为“Potentialbenefits of preci

The Lancet: 冠状病毒的肠道感染:SARS-CoV-2的粪口传播的可能性

讨论了新型冠状病毒粪口传播的可能性。

medRxiv: 新型冠状病毒(2019-nCoV)爆发期间机构信任在疫情预防和治疗中的作用

宁波大学医学院浙江省病理生理学技术研究重点实验室在medRxiv预印本平台发布“The role of institutional trust in preventive andtreat

Stabilitech公司开发出COVID-19疫苗的口服胶囊,患者可自行服用

Stabilitech Biopharma 公司宣布已经开发出新型的用于递送COVID-19疫苗的口服胶囊,该新型冠状病毒疫苗安全、有效并且可以让患者自行服用。

International J ofInfectious D: 瑞金医院等团队基于数据驱动分析估计钻石公主号游轮上COVID-19的基本繁殖数和暴发规模

上海交通大学医学院附属瑞金医院、浙江大学医学院附属杭州市第一人民医院、海军军医大学(第二军医大学)